Selected article for: "serum folate and study cobalamin evaluate"

Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
  • ID: 3pnuj5ru_403
    Snippet: This study suggests that lipoprotein profiles are altered in dogs with CE. Investigating clinical importance of lipoprotein profiling in dogs with CE is warranted. In humans, hyperhomocysteinemia is a multifactorial and incompletely understood condition. Increased serum homocysteine (HCY) concentrations have been associated with cardiovascular disease, peripheral arterial occlusive disease, and venous thrombosis. Recently, cardiovascular/thrombot.....
    Document: This study suggests that lipoprotein profiles are altered in dogs with CE. Investigating clinical importance of lipoprotein profiling in dogs with CE is warranted. In humans, hyperhomocysteinemia is a multifactorial and incompletely understood condition. Increased serum homocysteine (HCY) concentrations have been associated with cardiovascular disease, peripheral arterial occlusive disease, and venous thrombosis. Recently, cardiovascular/thrombotic disease and hypocobalaminemia have been described in Greyhounds. It was also suggested that hyperhomocysteinemia in Greyhounds with suspected gastrointestinal disease is due to hypocobalaminemia and hypofolatemia. Both conditions have also been linked to hypoalbuminemia, which may affect HCY levels, as shown previously in dogs. However, it is unknown if low levels of both micronutrients (cobalamin and/or folate) are present only in Greyhounds with gastrointestinal disease or also in healthy Greyhounds. Therefore, the aim of this study was to evaluate serum HCY, cobalamin, and folate concentrations in Greyhounds with diarrhea or thrombotic disease as well as in healthy Greyhounds.

    Search related documents:
    Co phrase search for related documents
    • arterial occlusive disease and occlusive disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • arterial occlusive disease and peripheral arterial occlusive disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • arterial occlusive disease and study aim: 1, 2
    • arterial occlusive disease and thrombotic disease: 1
    • arterial occlusive disease and venous thrombosis: 1, 2
    • cardiovascular disease and clinical importance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cardiovascular disease and condition understand: 1
    • cardiovascular disease and gastrointestinal disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cardiovascular disease and HCY concentration: 1
    • cardiovascular disease and lipoprotein profile: 1, 2, 3
    • cardiovascular disease and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cardiovascular disease and occlusive disease: 1
    • cardiovascular disease and peripheral arterial occlusive disease: 1
    • cardiovascular disease and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • cardiovascular disease and thrombotic disease: 1, 2, 3, 4, 5, 6
    • cardiovascular disease and venous thrombosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cardiovascular thrombotic disease and low level: 1
    • cardiovascular thrombotic disease and study aim: 1
    • cardiovascular thrombotic disease and thrombotic disease: 1, 2, 3